Pharma Focus America

News

Are you looking for recent Pharma Magazine information?
Check out the Top News in Pharma Magazine, Leading Magazine in the Pharma Industry, and most recent pharmaceutical news. Daily information updates related to the industrial sectors we work in are presented in the pharmaceutical industry's news area

Viatris and Kindeva Unveil Breyna™: FDA-Approved Generic Inhalation Aerosol for Asthma and COPD Patients

Monday, July 31, 2023

Viatris Inc NASDAQ VTRS and Kindeva Drug Delivery LP have introduced Breyna budesonide and formoterol fumarate dihydrate Inhalation Aerosol marking the first generic version of AstraZenecas Symbicort

FDA Grants Fast Track Designation to CAR-T Cell Therapy IVS-3001 for Renal Cell Carcinoma Treatment

Monday, July 31, 2023

Invectys a clinicalstage immunooncology company focusing on developing innovative therapies for advanced cancers has exciting news to share

Biogen to Acquire Reata Pharmaceuticals

Saturday, July 29, 2023

Biogen Inc Nasdaq BIIB and Reata Pharmaceuticals Inc Nasdaq RETA today announced the companies have entered into a definitive agreement under which Biogen has agreed to acquire Reata for per share in cash reflecting an enterprise value of approximat...

Chinook Therapeutics Initiates Pivotal Phase 3 BEYOND Trial of Zigakibart (BION-1301) for IgA Nephropathy Patients

Saturday, July 29, 2023

Chinook Therapeutics Inc Nasdaq KDNY a biopharmaceutical company specializing in precision medicines for kidney diseases has announced the enrollment of the first patient with IgA nephropathy IgAN in the BEYOND study This study is a pivotal phase cl...

Disc Medicine Commences Phase 1/2 Clinical Trial of Bitopertin for Diamond-Blackfan Anemia (DBA) with First Patient Enrollment

Friday, July 28, 2023

Disc Medicine Commences Phase Clinical Trial of Bitopertin for DiamondBlackfan Anemia DBA with First Patient Enrollment

Avenue Therapeutics Initiates Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Kennedy's Disease (Spinal and Bulbar Muscular Atrophy)

Friday, July 28, 2023

Avenue Therapeutics Inc Nasdaq ATXI has initiated a Phase ba clinical trial for their lead drug candidate AJ which is designed to treat spinal and bulbar muscular atrophy SBMA commonly known as Kennedys Disease

Humacyte's Phase 2/3 Trial of Human Acellular Vessel™ (HAV™) for Vascular Trauma Repair Reaches Full Enrollment

Thursday, July 27, 2023

Humacyte a clinicalstage biotechnology platform company Nasdaq HUMA has achieved full enrollment in its Phase vascular trauma trial V

Pint Pharma's EMPAVELI® (pegcetacoplan) Receives Regulatory Approval as the First Targeted Therapy for Paroxysmal Nocturnal Hemoglobinuria (PNH) in Adults

Thursday, July 27, 2023

OrphanDC and Pint Pharma Secure ANVISA Approval for EMPAVELI pegcetacoplan a Groundbreaking Targeted Therapy for Paroxysmal Nocturnal Hemoglobinuria PNH in Adults

FDA Accepts Supplemental New Drug Application for OFEV® (nintedanib) for Treatment of Fibrosing Interstitial Lung Disease in Children and Adolescents Aged 6-17 Years

Wednesday, July 26, 2023

Boehringer Ingelheim has announced that the US Food and Drug Administration FDA accepted their supplemental New Drug Application sNDA for OFEV nintedanib

FDA Approves XDEMVY™ (Lotilaner Ophthalmic Solution) 0.25% for Demodex Blepharitis Treatment

Wednesday, July 26, 2023

Tarsus Pharmaceuticals Inc NASDAQ TARS has received approval from the US Food and Drug Administration FDA for XDEMVY lotilaner ophthalmic solution